The term microbicide refers to a new type of product being developed that people could use vaginally or rectally to protect themselves from HIV and possibly other sexually transmitted infections. A microbicide could be produced in many forms, including gels, creams, suppositories, films, or as a sponge or ring that releases the active ingredient over time. Pre-exposure prophylaxis (PrEP) involves HIV-negative people taking antiretrovirals (ARVs)—the same drugs used to treat HIV—to prevent becoming HIV-infected.

PHRU researchers are investigating these and other novel approaches for the prevention of HIV.


Clinical Trials and Research

PHRU conducts research into microbicides and PrEP as part of the HIV Prevention Trials Network (HPTN) and the Microbicides Trials Network (MTN).

Learn more about our ongoing clinical trials and research studies.

Microbicide Trials Network (MTN): Soweto Clinical Research Site.

HIV Prevention Trials Network (HPTN): Soweto Clinical Research Site.


Health Information

Learn more about microbicides and PrEP.